Interestingly, in other BRCA1-methylated PDX tumours, BRCA1 re-expression was determined by de novo intrachromosomal genomic rearrangements through which BRCA1 transcription is placed under the control of a heterologous promoter [47]. Here, BRCA1 is linked to neoplasm.